Clinical Trial Update: MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for MK-5442 in treating osteoporosis in postmenopausal women previously treated with an oral bisphosphonate; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• MK-5442

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis, Postmenopausal Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2012-11-16